Articles with public access mandates - Linda A. DiMeglioLearn more
Not available anywhere: 4
The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis.
BA Buckingham, RW Beck, KJ Ruedy, P Cheng, C Kollman, ...
Diabetes Technology & Therapeutics 15 (5), 401-408, 2013
Mandates: US National Institutes of Health
Effects of recombinant human growth hormone on protein turnover in the fasting and fed state in adolescents with Crohn disease
TS Hannon, LA DiMeglio, MD Pfefferkorn, AE Carroll, SC Denne
Walter de Gruyter 24 (9-10), 633-640, 2011
Mandates: US National Institutes of Health
Twelve‐month psychosocial outcomes of continuous glucose monitoring with behavioural support in parents of young children with type 1 diabetes
PV Commissariat, LA DiMeglio, LG Kanapka, LM Laffel, KM Miller, ...
Diabetic Medicine 40 (8), e15120, 2023
Mandates: US National Institutes of Health
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6 …
DS Fox, J Ware, CK Boughton, JM Allen, ME Wilinska, M Tauschmann, ...
Journal of Diabetes Science and Technology, 19322968241231950, 2024
Mandates: National Institute for Health Research, UK, Wellcome Trust
Available somewhere: 148
State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018
C FosterNicole, W BeckRoy, M MillerKellee, A ClementsMark, ...
Diabetes technology & therapeutics, 2019
Mandates: US National Institutes of Health
Type 1 diabetes
LA DiMeglio, C Evans-Molina, RA Oram
The Lancet 391 (10138), 2449-2462, 2018
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry
KM Miller, NC Foster, RW Beck, RM Bergenstal, SN DuBose, LA DiMeglio, ...
Diabetes care 38 (6), 971-978, 2015
Mandates: US National Institutes of Health
An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes
KC Herold, BN Bundy, SA Long, JA Bluestone, LA DiMeglio, MJ Dufort, ...
New England Journal of Medicine 381 (7), 603-613, 2019
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9789), 412-419, 2011
Mandates: US National Institutes of Health
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes …
JR Wood, KM Miller, DM Maahs, RW Beck, LA DiMeglio, IM Libman, ...
Diabetes care 36 (7), 2035-2037, 2013
Mandates: US National Institutes of Health
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
DK Wherrett, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 378 (9788), 319-327, 2011
Mandates: US National Institutes of Health
Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
A Moran, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
The Lancet 381 (9881), 1905-1915, 2013
Mandates: US National Institutes of Health
Racial-ethnic disparities in management and outcomes among children with type 1 diabetes
SM Willi, KM Miller, LA DiMeglio, GJ Klingensmith, JH Simmons, ...
Pediatrics 135 (3), 424-434, 2015
Mandates: US National Institutes of Health
Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes
M Battaglia, S Ahmed, MS Anderson, MA Atkinson, D Becker, PJ Bingley, ...
Diabetes care 43 (1), 5-12, 2020
Mandates: US National Institutes of Health, US Department of Veterans Affairs, UK …
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients
MR Rigby, KM Harris, A Pinckney, LA DiMeglio, MS Rendell, EI Felner, ...
The Journal of clinical investigation 125 (8), 3285-3296, 2016
Mandates: US National Institutes of Health
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment
T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
Diabetes care 37 (4), 1069-1075, 2014
Mandates: US National Institutes of Health, UK Medical Research Council, Juvenile …
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial
MR Rigby, LA DiMeglio, MS Rendell, EI Felner, JM Dostou, SE Gitelman, ...
The lancet Diabetes & endocrinology 1 (4), 284-294, 2013
Mandates: US National Institutes of Health
Intensified effect of adiposity on blood pressure in overweight and obese children
W Tu, GJ Eckert, LA DiMeglio, Z Yu, J Jung, JH Pratt
Hypertension 58 (5), 818-824, 2011
Mandates: US National Institutes of Health
Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes: a randomized clinical trial
IM Libman, KM Miller, LA DiMeglio, KE Bethin, ML Katz, A Shah, ...
Jama 314 (21), 2241-2250, 2015
Mandates: US National Institutes of Health, Juvenile Diabetes Research Foundation
Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations
EA Imel, LA DiMeglio, SL Hui, TO Carpenter, MJ Econs
The Journal of Clinical Endocrinology & Metabolism 95 (4), 1846-1850, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program